All In Biotech

Drug Trial Radar · NCT04130802

OCS-01 in Treating Inflammation and Pain in Post-cataract Patients

A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of Two Doses of OCS 01 Compared to Vehicle in the Treatment of Inflammation and Pain Following Cataract Surgery

Last checked: Nov 19, 2026Latest source record: Sep 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 153 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

153

Actual

Start

Sep 27, 2019

Primary completion

Jan 31, 2020

Study completion Jan 31, 2020

Sponsor

Lead sponsor
OculisIndustry
Sponsor type
Industry
First posted
Oct 17, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The DX-216 trial is a randomized, double-masked, placebo (vehicle)-controlled study evaluating the efficacy and safety of two doses of OCS-01 compared to vehicle in the treatment of inflammation and pain following cataract surgery. The primary objective is to evaluate the efficacy and safety of OCS-01 compared to placebo and the secondary objective is to evaluate the optimal dosing frequency (once a day \[QD\] or twice a day \[BID\]).

Conditions

  • Inflammation Corneal
  • Pain, Postoperative

Interventions

  • OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mLDrug

    OCS-01 eye drops

  • PlaceboDrug

    Vehicle eye drops

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With Absence of Anterior Chamber Cells (i.e. Score of '0')Time frame: at Day 15 (visit 6)
  2. Number of Subjects With Absence of Ocular Pain (i.e. Score of '0')Time frame: at Day 4 (visit 4)

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Medical cennre

    Petaluma, California

  • Medical center

    Roseburg, Oregon

  • Medical center

    Houston, Texas

  • Medical center

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.